The IRS' new policy, which will bolster compliance with Obamacare, comes as the Trump administration takes actions to undercut the law. » Read More
By: Dan Mangan
The bill would restore billions of dollars in payments to Obamacare insurers, many of whom hiked prices to anticipate the payments ending. » Read More
The individual mandate requires most people to have health insurance or pay a fine. » Read More
Iceland is deciphering the genetic codes of its citizens to learn what factors can cause a form of blood cancer.
Recent moves by Gov. John Kasich are alarming pain sufferers who have relied on medications that could be restricted, NBC reports.
More than three years after a regulatory crackdown, 23andMe is now back to offering nearly all of its direct-to-consumer genetic tests.
If the law implodes, it won’t work in Republicans favor, Vox reports.
Smoking is the root cause of one in 10 deaths worldwide – and half occur within just four countries, according to a new study.
The GOP has long criticized single-payer health care as 'socialistic,' yet Trump conservatives think otherwise, says Dylan Matthews.
Japan's Takeda Pharmaceutical said on Wednesday it had completed enrolment for a 20,000-subject dengue vaccine trial.
The blood-testing start-up has the power to absolve her from the debt, according to the Wall Street Journal.
Republican are continuing to discuss reviving a bill that seeks to repeal and replace major parts of the Affordable Care Act.
Conservative House Republicans have been discussing several provisions that could lead them to support a replacement plan.
The provision requires insurers to cover the basics like prescriptions and hospitalization. The GOP wants to get rid of it, Vox reports.
The U.S. government slightly improved its final payment rate for health insurers who offer Medicare Advantage plans.
It would have been better to start with tax reform or infrastructure, Sen. Bob Corker tells CNBC.
White House officials made a new offer to conservative House Republicans late Monday on the GOP's failed health care bill, hoping to resuscitate a measure that crashed spectacularly less than two weeks ago.
Mylan has been under fire since last summer over price increases of its anti-allergy auto-injector device.
United Therapeutics said it would be delaying the launch of an implantable pump until 2018.
Cancer research and treatment company Novocure announced positive results in its experimental treatment.
Mylan announced Friday that it is expanding its voluntary EpiPen recall to include units in the United States.
"Huge shocks from the political system are always a distraction," athenahealth's Jonathan Bush told CNBC.
Owlet wants new parents to get some sleep, and its founder explains to CNBC how its sock is positioning itself to be a health tool.
Get the best of CNBC in your inbox